Experimental modeling of cancer typically uses in vitro culture of transformed cell lines or in vivo animal models. A new study using CRISPR-Cas9 to engineer oncogenic mutations into three-dimensional human colon organoid cultures yields insights into colorectal cancer tumorigenesis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation
Oncogene Open Access 19 June 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ghajar, C.M. & Bissell, M.J. Tissue Eng. Part A 16, 2153–2156 (2010).
Sato, T. & Clevers, H. Science 340, 1190–1194 (2013).
Sato, T. et al. Nature 459, 262–265 (2009).
Sato, T. et al. Gastroenterology 141, 1762–1772 (2011).
Spence, J.R. et al. Nature 470, 105–109 (2011).
Li, X. et al. Nat. Med. 20, 769–777 (2014).
Ootani, A. et al. Nat. Med. 15, 701–706 (2009).
Vogelstein, B. et al. Science 339, 1546–1558 (2013).
Matano, M. et al. Nat. Med. 21, 256–262 (2015).
Cancer Genome Atlas Network. Nature 487, 330–337 (2012).
Lawrence, M.S. et al. Nature 505, 495–501 (2014).
Boj, S.F. et al. Cell 160, 324–338 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.J.K. is an inventor on a pending patent describing organoid culture methodologies.
Rights and permissions
About this article
Cite this article
Salahudeen, A., Kuo, C. Toward recreating colon cancer in human organoids. Nat Med 21, 215–216 (2015). https://doi.org/10.1038/nm.3818
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3818